K. Stenzel

Synthesis of peptoid-based class I selective histone deacetylase inhibitors with chemosensitizing properties.

H. Gohlke, F. Hansen, T. Kurz, 2019, Journal of medicinal chemistry.

Alkoxyurea-Based Histone Deacetylase Inhibitors Increase Cisplatin Potency in Chemoresistant Cancer Cell Lines.

H. Gohlke, C. Romier, F. Hansen, 2017, Journal of medicinal chemistry.

One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.

E. Winzeler, S. Meister, F. Hansen, 2018, European journal of medicinal chemistry.

Isophthalic Acid‐Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoni

W. Sippl, C. Romier, F. Hansen, 2017, Archiv der Pharmazie.

Frequency distribution of cytokine and associated transcription factor single nucleotide polymorphisms in Zimbabweans: Impact on schistosome infection and cytokine levels

T. Mduluza, K. Stenzel, F. Mutapi, 2022, PLoS neglected tropical diseases.

Design and Synthesis of Terephthalic Acid‐Based Histone Deacetylase Inhibitors with Dual‐Stage Anti‐Plasmodium Activity

E. Winzeler, S. Meister, F. Hansen, 2017, ChemMedChem.

Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages.

E. Winzeler, S. Meister, B. Mordmüller, 2014, European journal of medicinal chemistry.

Poly[[[diaquacobalt(II)]‐di‐μ‐glycine] dichloride]

K. Stenzel, M. Fleck, 2004 .